SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sequent Scientific informs about press release

15 Feb 2021 Evaluate
Sequent Scientific has informed that it has enclosed copies of the newspaper advertisement regarding completion of dispatch of Notice of Postal Ballot dated February 08, 2021, published on February 13, 2021 in Financial Express (English language-All edition) and Mumbai Lakshadeep (Marathi language-Mumbai edition). A copy of said advertisement is also hosted on the Company's website at www.sequent.in

The above information is a part of company’s filings submitted to BSE.


Viyash Scientific Share Price

221.15 -4.15 (-1.84%)
12-May-2026 11:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1877.50
Dr. Reddys Lab 1286.00
Cipla 1306.60
Zydus Lifesciences 943.40
Lupin 2271.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×